scispace - formally typeset
Journal ArticleDOI

Therapeutic potential of resveratrol: the in vivo evidence.

Joseph A. Baur, +1 more
- 01 Jun 2006 - 
- Vol. 5, Iss: 6, pp 493-506
Reads0
Chats0
TLDR
A comprehensive and critical review of the in vivo data on resveratrol is provided, and its potential as a therapeutic for humans is considered.
Abstract
Resveratrol, a constituent of red wine, has long been suspected to have cardioprotective effects. Interest in this compound has been renewed in recent years, first from its identification as a chemopreventive agent for skin cancer, and subsequently from reports that it activates sirtuin deacetylases and extends the lifespans of lower organisms. Despite scepticism concerning its bioavailability, a growing body of in vivo evidence indicates that resveratrol has protective effects in rodent models of stress and disease. Here, we provide a comprehensive and critical review of the in vivo data on resveratrol, and consider its potential as a therapeutic for humans.

read more

Citations
More filters
Journal ArticleDOI

The role of sirtuins in cardiac disease

TL;DR: Seven sirtuin family proteins have been identified as mammalian SIR2 orthologs, localized in different subcellular compartments, namely, the cytoplasm, the mitochondria, and the nucleus (Sirt1-7), which has been the most intensively investigated in the cardiovascular system.
Journal ArticleDOI

Resveratrol improves non-alcoholic fatty liver disease by activating AMP-activated protein kinase.

TL;DR: Both in vivo and in vitro studies showed that RSV treatment could promote the phosphorylation of AMPK, which in this study, suppressed 2 lipogenesis gene expressions, contributing to the improvement of NAFLD and IR.
Journal ArticleDOI

Recent Development of Multifunctional Agents as Potential Drug Candidates for the Treatment of Alzheimer's Disease

TL;DR: The majority of the recently reported structures are acetylcholinesterase inhibitors, often endowed with some additional properties giving hope for not only symptomatic but also causal treatment of the disease.
Journal ArticleDOI

Chemistry and Biology of Resveratrol-Derived Natural Products

TL;DR: The history and recent progress in the isolation, chemical synthesis, and biology of this fascinating class of phytochemicals is documented, while providing new insight on the biosynthesis and future prospects for the field as a whole is provided.
Journal ArticleDOI

Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease.

TL;DR: For the treatment of NAFLD, 12 weeks of supplementation of 500 mg resveratrol, along with lifestyle modification, is superior to lifestyle modification alone, at least partially due to the attenuation of inflammatory markers and hepatocellular apoptosis.
References
More filters
Journal ArticleDOI

Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs

TL;DR: Experiments with guinea-pig lung suggest that some of the therapeutic effects of sodium salicylate and aspirin-like drugs are due to inhibition of the synthesis of prostaglandins.
Journal ArticleDOI

Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes

TL;DR: It is suggested that resveratrol, a common constituent of the human diet, merits investigation as a potential cancer chemopreventive agent in humans.
Journal ArticleDOI

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

TL;DR: The potent activator resveratrol, a polyphenol found in red wine, lowers the Michaelis constant of SIRT1 for both the acetylated substrate and NAD+, and increases cell survival by stimulating Sirt1-dependent deacetylation of p53.
Journal ArticleDOI

Wine, alcohol, platelets, and the French paradox for coronary heart disease

TL;DR: Data from Caerphilly, Wales, show that platelet aggregation, which is related to CHD, is inhibited significantly by alcohol at levels of intake associated with reduced risk of CHD.
Journal ArticleDOI

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.

TL;DR: A balance between formation of anti- and pro-aggregatory substances by enzymes could also contribute to the maintenance of the integrity of vascular endothelium and explain the mechanism of formation of intra-arterial thrombi in certain physiopathological conditions.
Related Papers (5)